Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Stoke Therapeutics, Inc. (STOK)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Mar 2024
Ticho Barry
CHIEF MEDICAL OFFICER, Officer
Stoke Therapeutics, Inc.
(STOK)
2,485
-80%
10,000
$7.75
$77,469.00
SELL
1 Feb 2024
Ticho Barry
CHIEF MEDICAL OFFICER, Officer
Stoke Therapeutics, Inc.
(STOK)
6,981
-58%
10,000
$4.80
$47,991.00
SELL
2 Jan 2024
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
16,981
-37%
10,000
$5.74
$57,352.00
SELL
3 Jul 2023
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
25,895
-36%
15,000
$10.60
$158,973.00
SELL
21 Jun 2023
Allan Jonathan
General Counsel & Corp Sec, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
1,948
$13.48
$26,252.22
SELL
1 Jun 2023
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
40,895
-26%
15,000
$11.13
$166,963.50
SELL
4 May 2023
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
55,895
-1%
653
$10.00
$6,530.00
SELL
1 May 2023
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
56,548
-49%
55,177
$10.06
$555,267.06
SELL
3 Feb 2023
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
111,725
-10%
12,998
$10.02
$130,236.44
SELL
31 Jan 2023
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
124,723
-4%
6,172
$10.01
$61,810.14
SELL
3 Jan 2022
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,303
-62%
3,800
$23.07
$87,666.13
SELL
1 Dec 2021
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,500
-69%
5,700
$24.44
$139,329.61
SELL
1 Nov 2021
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
5,700
$24.03
$136,956.48
SELL
1 Oct 2021
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
5,700
$24.83
$141,505.92
SELL
1 Sep 2021
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
5,700
$26.00
$148,222.80
SELL
2 Aug 2021
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
5,700
$28.87
$164,554.44
SELL
13 Jul 2021
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
134,195
-24%
43,166
$32.75
$1,413,654.00
SELL
1 Jul 2021
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
5,700
$33.33
$189,986.70
SELL
1 Jun 2021
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
575
$39.43
$22,669.49
SELL
1 Mar 2021
LEVIN ARTHUR A
Director
Stoke Therapeutics, Inc.
(STOK)
4,957
-71%
12,500
$60.79
$759,841.10
SELL
22 Feb 2021
Tulipano Stephen J
CFO, Officer
Stoke Therapeutics, Inc.
(STOK)
602
-98%
30,000
$58.86
$1,765,895.80
SELL
19 Feb 2021
TZIANABOS ARTHUR
Director
Stoke Therapeutics, Inc.
(STOK)
0
-100%
10,000
$60.67
$606,652.00
SELL
4 Jan 2021
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
5,732
$58.96
$337,985.40
SELL
28 Dec 2020
Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
24,251
-18%
5,344
$62.93
$336,297.16
SELL
21 Dec 2020
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
174,053
-0%
1,365
$57.62
$78,654.05
SELL
17 Dec 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
50,000
$60.00
$3,000,000.00
SELL
17 Dec 2020
Kaye Edward M. MD
CEO, Director, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
25,000
$60.00
$1,500,000.00
SELL
1 Dec 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,981
-65%
5,700
$49.84
$284,079.62
SELL
27 Nov 2020
Kaye Edward M. MD
CEO, Director, Officer
Stoke Therapeutics, Inc.
(STOK)
25,000
-32%
12,152
$50.00
$607,600.00
SELL
25 Nov 2020
Kaye Edward M. MD
CEO, Director, Officer
Stoke Therapeutics, Inc.
(STOK)
37,152
-25%
12,848
$50.00
$642,400.00
BUY
24 Nov 2020
Harrison Seth Loring
Director, 10% Owner
Stoke Therapeutics, Inc.
(STOK)
17,161,712
+2%
375,000
$39.00
$14,625,000.00
BUY
24 Nov 2020
Apple Tree Partners IV, L.P.
10% Owner
Stoke Therapeutics, Inc.
(STOK)
17,161,712
+2%
375,000
$39.00
$14,625,000.00
SELL
23 Nov 2020
TZIANABOS ARTHUR
Director
Stoke Therapeutics, Inc.
(STOK)
15,700
-56%
20,000
$46.03
$920,565.70
SELL
10 Nov 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
50,000
$45.00
$2,250,000.00
SELL
2 Nov 2020
Tulipano Stephen J
CFO, Officer
Stoke Therapeutics, Inc.
(STOK)
16,929
-80%
70,000
$39.00
$2,729,938.50
SELL
2 Nov 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,536
-69%
5,700
$37.21
$212,109.89
SELL
16 Oct 2020
Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
20,725
-64%
37,851
$38.16
$1,444,205.80
SELL
13 Oct 2020
Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
13,500
-10%
1,649
$40.00
$65,960.00
SELL
1 Oct 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
2,300
-71%
5,700
$34.54
$196,900.53
SELL
8 Sep 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
47,919
$30.00
$1,437,570.00
SELL
1 Sep 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
700
-89%
5,700
$27.74
$158,112.62
SELL
28 Aug 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
2,081
$30.00
$62,430.00
SELL
3 Aug 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
5,700
$24.73
$140,943.33
SELL
16 Jul 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
1,900
$25.06
$47,614.00
SELL
7 Jul 2020
Walker Robin A.
Chief Legal Officer, CCO & Sec, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
941
$22.50
$21,172.50
SELL
7 Jul 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
913
$22.41
$20,456.86
SELL
1 Jul 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
0
-100%
3,800
$23.15
$87,967.73
SELL
1 Jun 2020
Ticho Barry
Chief Medical Officer, Officer
Stoke Therapeutics, Inc.
(STOK)
173,027
-0%
1,365
$27.39
$37,386.70
SELL
1 Jun 2020
Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
22,605
-46%
20,000
$26.35
$527,036.80
SELL
1 Jun 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
500
-80%
2,107
$27.18
$57,263.26
SELL
22 May 2020
Liau Gene
EVP Research & Preclinical Dev, Officer
Stoke Therapeutics, Inc.
(STOK)
13,500
-35%
7,500
$30.00
$225,000.00
SELL
2 Mar 2020
Nash Huw M.
COO & CBO, Officer
Stoke Therapeutics, Inc.
(STOK)
15,995
-75%
49,143
$25.89
$1,272,549.20
SELL
8 Nov 2019
RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,544,248
-0%
16,434
$28.70
$471,631.16
BUY
4 Nov 2019
RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,560,682
+3%
104,873
$29.24
$3,066,843.20
BUY
30 Oct 2019
RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,455,809
+2%
68,783
$28.59
$1,966,612.90
BUY
1 Oct 2019
RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,387,026
+0%
31,560
$21.96
$693,029.25
BUY
21 Jun 2019
Harrison Seth Loring
Director, 10% Owner
Stoke Therapeutics, Inc.
(STOK)
16,786,712
+9%
1,388,889
$18.00
$25,000,002.00
BUY
21 Jun 2019
Apple Tree Partners IV, L.P.
10% Owner
Stoke Therapeutics, Inc.
(STOK)
16,786,712
+9%
1,388,889
$18.00
$25,000,002.00
BUY
19 Jun 2019
RTW INVESTMENTS, LP
10% Owner
Stoke Therapeutics, Inc.
(STOK)
3,355,466
+19%
555,556
$18.00
$10,000,008.00
Home